127799-53-5 Usage
Description
1-(benzyloxy)carbonyl-2-(t-butyloxy)carbonyl-1-Methylhydrazine is a complex organic chemical compound characterized by the presence of a benzyl group, a t-butyl group, and two carbonyl groups attached to a methylhydrazine molecule. 1-(benzylo×y)carbonyl-2-(t-butylo×y)carbonyl-1-Methylhydrazine serves as a versatile intermediate in organic synthesis, particularly in the pharmaceutical and agrochemical industries, due to its unique structural features that influence reactivity and stability.
Uses
Used in Pharmaceutical Industry:
1-(benzyloxy)carbonyl-2-(t-butyloxy)carbonyl-1-Methylhydrazine is utilized as a key building block in the synthesis of various pharmaceuticals. Its unique structure allows for the development of potential drug candidates with specific therapeutic properties. The benzyl and t-butyl groups contribute to the compound's reactivity, enabling the formation of new chemical entities with desired pharmacological activities.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(benzyloxy)carbonyl-2-(t-butyloxy)carbonyl-1-Methylhydrazine serves as an essential component in the creation of novel agrochemicals. Its structural attributes make it a valuable precursor in the synthesis of compounds with pesticidal, herbicidal, or other agricultural applications. 1-(benzylo×y)carbonyl-2-(t-butylo×y)carbonyl-1-Methylhydrazine's versatility in organic synthesis facilitates the development of innovative agrochemicals to address various agricultural challenges.
Used in Chemical Synthesis:
1-(benzyloxy)carbonyl-2-(t-butyloxy)carbonyl-1-Methylhydrazine is employed as an intermediate in various chemical reactions, allowing for the formation of a wide range of organic compounds. Its presence in the molecule can influence the reactivity and stability of the resulting products, making it a crucial component in the synthesis of new materials and chemical entities.
Used in Drug Discovery:
Researchers actively explore the potential applications of 1-(benzyloxy)carbonyl-2-(t-butyloxy)carbonyl-1-Methylhydrazine in drug discovery. Its unique structural features and reactivity make it a promising candidate for the development of new therapeutic agents. 1-(benzylo×y)carbonyl-2-(t-butylo×y)carbonyl-1-Methylhydrazine's versatility in organic synthesis enables the creation of diverse drug candidates with potential applications in various medical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 127799-53-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,7,7,9 and 9 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 127799-53:
(8*1)+(7*2)+(6*7)+(5*7)+(4*9)+(3*9)+(2*5)+(1*3)=175
175 % 10 = 5
So 127799-53-5 is a valid CAS Registry Number.
127799-53-5Relevant articles and documents
FACTOR XIA-INHIBITING PYRIDOBENZAZEPINE AND PYRIDOBENZAZOCINE DERIVATIVES
-
Paragraph 0511-0512, (2017/10/10)
The invention relates to substituted pyridobenzazepine and pyridobenzazocine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
SUBSTITUTED OXOPYRIDINE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISORDERS
-
Paragraph 0791-0794, (2016/10/07)
The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
Very efficient one-pot conversion of N-aminophthalimide derivatives into the corresponding N-amino-di-tert-butyl imidodicarbonates
Brosse, Nicolas,Jamart-Grégoire, Brigitte
, p. 249 - 251 (2007/10/03)
The phthaloyl group can be efficiently converted in very mild conditions into bis-tert-butyloxycarbonyl group using MeNH2, then Boc2O/DMAP, in a one-flask protocol.